First-generation H1 antihistamine; crosses the blood-brain barrier and produces sedation via H1 blockade. Strong anticholinergic — Beers-list problematic in elderly. OTC for allergy + sleep.
Half-Life & Elimination Curve (PO: 8h · IV: 8h)
Plasma (PO)t½ Decay (8h)Effect Site (ke0)
0×t½0h100%(98 µg/L)
1×t½8h50%(49 µg/L)
2×t½16h25%(24.5 µg/L)
3×t½24h12.5%(12.3 µg/L)
4×t½32h6.3%(6.13 µg/L)
5×t½40h3.1%(3.06 µg/L)
Elimination t½8h (PO)
Rate Constant (ke)0.0866 h⁻¹
Time to Peak (Tmax)1.77h
Est. Peak (Cmax)98 µg/L
Clearance (CL)27.3 L/h
97% Washout (5×t½)40h
Dosing Guidelines
Oral (PO): Typical 50 mg (Range: 25–50 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 72% · Volume of Distribution (Vd): 315 L · Absorption (ka): 1.8 h⁻¹ (t½ka ≈ 23m) [PMID 3760245]
Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 315 L [PMID 3760245]